SCHEMBL3967663

SCHEMBL3967663

COc1cc2c(cc1C(N)=O)C(=O)C(=NO)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
ALDH1A1 P00352 2/20 0.41
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
CES2 O00748 2/20 0.34
CHEK1 O14757 1/20 0.34
PARP15 Q460N3 1/20 0.33
PARP10 Q53GL7 1/20 0.33
MAPT P10636 1/20 0.33
ABCB1 P08183 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3967662 1.00 CYP1A2 (0.41) CYP1A2CYP2C19ALDH1A1CYP3A4CYP2C9
SCHEMBL3973728 0.84 ALDH1A1 (0.39) CYP1A2CYP2C19ALDH1A1CYP3A4CES2
SCHEMBL3973729 0.84 ALDH1A1 (0.39) CYP1A2CYP2C19ALDH1A1CYP3A4CES2
SCHEMBL1027980 0.84 ALDH1A1 (0.49) CYP1A2CYP2C19ALDH1A1CYP3A4MAPT
SCHEMBL3969245 0.84 ALDH1A1 (0.49) CYP1A2CYP2C19ALDH1A1CYP3A4MAPT
SCHEMBL1027979 0.84 ALDH1A1 (0.49) CYP1A2CYP2C19ALDH1A1CYP3A4MAPT
SCHEMBL4213724 0.80 ALDH1A1 (0.45) CYP1A2CYP2C19ALDH1A1CYP3A4TSHR
SCHEMBL4213720 0.80 ALDH1A1 (0.45) CYP1A2CYP2C19ALDH1A1CYP3A4TSHR
SCHEMBL13716891 0.80 ALDH1A1 (0.45) CYP1A2CYP2C19ALDH1A1CYP3A4TSHR
SCHEMBL3972966 0.79 ALDH1A1 (0.44) CYP1A2CYP2C19ALDH1A1CYP3A4CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572809-B2 Isoquinoline aminopyrazole derivatives HOFFMANN-LA ROCHE INC. (US) 2009-08-11 US disclosed
EP-1966190-A1 ISOQUINOLINE AMINOPYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2008-09-10 EP disclosed
US-20070179151-A1 Isoquinoline aminopyrazole derivatives F. HOFMANN-LA ROCHE AG (CH) 2007-08-02 US disclosed
WO-2007071348-A1 ISOQUINOLINE AMINOPYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179151-A1 Isoquinoline aminopyrazole derivatives CYP3A5, CYP3A43, CYP3A4 CYP1A2 9/4885CYP2C19 17/4885ALDH1A1 198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.